GlassScriptPhysician profile
Avi H Schiowitz
NPI 1164436218
$1,773.14
in general payments reported to CMS, 2019-2025
20 companies · $71.72 in 2025
The $71.72 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $456 · 2020: $340 · 2021: $309 · 2022: $192 · 2023: $129 · 2024: $274 · 2025: $71.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $474.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $369.16 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $267.14 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $252.50 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $196.06 | 2019-2024 | Airsupra |
| Amgen INC. | $133.46 | 2023-2024 | Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.54 | 2023-2025 | Jardiance |
| Sanofi Pasteur INC. | $75.20 | 2019-2022 | |
| Exact Sciences Corporation | $64.38 | 2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $64.19 | 2019-2024 | Jardiance |
| Kowa Pharmaceuticals America, INC. | $48.48 | 2020-2021 | |
| Allergan, INC. | $41.60 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $33.44 | 2022 | |
| Abbvie INC. | $23.94 | 2023 | Linzess |
| Amarin Pharma, INC. | $21.74 | 2019 | |
| Antares Pharma, INC. | $18.69 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $18.17 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.47 | 2022 | |
| Phathom Pharmaceuticals, INC. | $15.41 | 2024 | Voquezna |
| Alexion Pharmaceuticals, INC. | $12.94 | 2021 | |
| Novo Nordisk INC | $11.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avi Schiowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.